Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank29
3Y CAGR-16.7%
5Y CAGR-32.7%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-16.7%/yr
vs -41.2%/yr prior
5Y CAGR
-32.7%/yr
Recent acceleration
Acceleration
+24.5pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.28+0.0%
20240.28-33.6%
20230.41-12.9%
20220.48-54.7%
20211.05-47.5%
20202.00+123.6%
2019-8.45-312.6%
20183.98-